Jazz Pharmaceuticals (JAZZ)

Company Ticker Sector | Industry Quality PAR
Jazz Pharmaceuticals JAZZ Healthcare | Biotechnology 94 16.7%
Current Price (09/20) $129.21
CAPS Rating (Rate this stock on CAPS) Foolcaps 4
Expected Income Statement
Current Sales 2,034.6
Sales Growth Forecast 13.2%
Net Profit Margin 45.9%
Projected Shares Outstanding 62.01
EPS - Five year Forecast $27.97
Average P/E Ratio 10.0
Projected Average Price $279.68
Price Appreciation (Annualized) 16.7%
Annual Dividend Yield 0.0%
Projected Annual Return 16.7%
Quality
Financial Strength 86 21.5
EPS Stability 94 23.5
Industry Sales Growth Rate 16.5% 10.0
Industry Net Profit Margin 29.0% 19.8
Calculated Quality Rating 74.7
Fool CAPS

Total Players

306 Outperforms
67 Underperforms
 

All-Stars (70)

55 Outperforms (79%)
15 Underperforms
 
Fundamental Data Updated: 06/28/2019

MIPAR 8.8%  
Sweet Spot 13.8% - 18.8%  

Top In Biotechnology

Ticker Quality PAR
JAZZ 94 16.7%
RGEN 72 19.1%
BSTC 77 16.0%
BIIB 77 15.4%
CELG 63 19.9%

Top In Healthcare

Ticker Quality PAR
ALGN 96 17.7%
JAZZ 94 16.7%
UNH 97 13.7%
ABBV 88 15.0%
BMY 93 23.9%